Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprotinin for transfusion reduction in elective spinal fusion surgery
2005-003999-38Phase 3Completed
- Sponsor
- Bayer
- Start
- Nov 2005
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in perioperative bleeding comparing Trasylol with Placebo (2 arms). Primary endpoint: Percent of patients requiring blood transfusion. Started Nov 2005; status: completed.
02
Drugs
aprotinin
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on 2005-003999-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003999-38.